Definitive Healthcare's ROE % for the quarter that ended in Mar. 2026 was -259.50%. Definitive Healthcare's PB Ratio for the quarter that ended in Mar. 2026 was 0.89.
Definitive Healthcare's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -291.57%.
Definitive Healthcare ROE % Adjusted to Book Value Related Terms
Definitive Healthcare ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Definitive Healthcare's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Definitive Healthcare ROE % Adjusted to Book Value Chart
DH vs OPRX, CCLD, HCAT: ROE % Adjusted to Book Value Comparison
For the Health Information Services subindustry, Definitive Healthcare's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Definitive Healthcare ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Definitive Healthcare's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -291.57% mean?
Definitive Healthcare (DH) has a ROE % Adjusted to Book Value of -291.57% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Definitive Healthcare and its competitors.
Is Definitive Healthcare's ROE % Adjusted to Book Value too high?
Definitive Healthcare's current ROE % Adjusted to Book Value is -291.57%. Overall, Definitive Healthcare has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Definitive Healthcare's ROE % Adjusted to Book Value compare to OPRX and CCLD?
Definitive Healthcare's ROE % Adjusted to Book Value of -291.57% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Definitive Healthcare and its competitors. Definitive Healthcare's current ROE % Adjusted to Book Value is -291.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Definitive Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Definitive Healthcare (DH) is currently considered Possible Value Trap. The stock's GF Value™ is $4.45, compared to a current price of $0.70 — trading 84.3% below its estimated fair value. The current ROE % Adjusted to Book Value is -291.57%. Definitive Healthcare's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Definitive Healthcare (DH), the current ROE % Adjusted to Book Value is -291.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Definitive Healthcare (DH) Overvalued in 2026?
Based on GuruFocus' analysis, Definitive Healthcare stock appears to be undervalued.
The current stock price of $0.70 is trading 84.3% below its estimated GF Value™ of $4.45.
GuruFocus considers Definitive Healthcare to be Possible Value Trap.
Key valuation signals for DH:
ROE % Adjusted to Book Value: -291.57%
GF Value™: $4.45 vs. price of $0.70 (84.3% below fair value)
No single metric tells the full story. See the DH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
51GF Score
Get the complete analysis for DH
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DH has been successfully added to your 
